Ivermectin 3mg Tablet Franchise in Ahmedabad

Antiparasitic Tablet Supplier in Bangalore

Ivermectin Tablet Distributor in Hyderabad

Parasitic Infection Treatment Franchise Opportunity in Jaipur

Anthelmintic Tablet Stockist in Mumbai
Ivermectin Tablet Export & Manufacturing in Chandigarh

Home/Products /ivermectin-3mg-tablet

Iverlim 3 Tablet

Composition : Ivermectin (3mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Iverlim 3 Tablet contains Ivermectin 3mg, a well-established antiparasitic agent widely used in the treatment of intestinal and external parasitic infections. It is effective against a broad range of parasites, including roundworms, mites, and lice, making it a trusted therapy in both hospital and outpatient settings.

Ivermectin works by interfering with parasite nerve and muscle function, leading to paralysis and elimination of the parasite from the body. Its proven efficacy, predictable absorption, and favorable safety profile have made it a commonly prescribed medicine for conditions such as strongyloidiasis, scabies, and other parasitic infestations.

For distributors and healthcare suppliers, Iverlim 3 Tablet is a high-rotation antiparasitic product, frequently demanded by general physicians, dermatologists, hospitals, and public health programs. Parasitic infections in tropical and semi-urban regions ensure steady and repeat market requirements.

Adding Iverlim 3 Tablet to your product portfolio strengthens your anti-infective and parasitic-care segment, creating opportunities across retail pharmacies, institutional supply, government tenders, export markets, and third-party manufacturing. Its wide therapeutic use and consistent demand make it a commercially valuable product for pharmaceutical distributors.

Read More

About the Product

Iverlim 3 Tablet contains Ivermectin 3mg, a well-established antiparasitic agent widely used in the treatment of intestinal and external parasitic infections. It is effective against a broad range of parasites, including roundworms, mites, and lice, making it a trusted therapy in both hospital and outpatient settings.

Ivermectin works by interfering with parasite nerve and muscle function, leading to paralysis and elimination of the parasite from the body. Its proven efficacy, predictable absorption, and favorable safety profile have made it a commonly prescribed medicine for conditions such as strongyloidiasis, scabies, and other parasitic infestations.

For distributors and healthcare suppliers, Iverlim 3 Tablet is a high-rotation antiparasitic product, frequently demanded by general physicians, dermatologists, hospitals, and public health programs. Parasitic infections in tropical and semi-urban regions ensure steady and repeat market requirements.

Adding Iverlim 3 Tablet to your product portfolio strengthens your anti-infective and parasitic-care segment, creating opportunities across retail pharmacies, institutional supply, government tenders, export markets, and third-party manufacturing. Its wide therapeutic use and consistent demand make it a commercially valuable product for pharmaceutical distributors.

Common side effects may include nausea, dizziness, diarrhea, abdominal pain, or headache. Some patients may experience mild skin reactions such as itching or rash. Most side effects are temporary, but medical advice should be sought if they persist or worsen.

Iverlim 3 Tablet is indicated for the treatment of parasitic infections such as strongyloidiasis, onchocerciasis, scabies, and other worm infestations, as prescribed by a healthcare professional. It helps in reducing symptoms and controlling the spread of parasitic diseases.

Iverlim 3 Tablet should be taken strictly as directed by a doctor. Dosage depends on body weight and type of infection. It is not recommended for self-medication, and caution is advised in patients with liver disorders or those taking other medications.

Store Iverlim 3 Tablet in a cool and dry place, protected from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.